Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၁.၄၁%
၁,၀၇၆.၁၃
-၁၅.၃၈
-၁.၄၁%
—၁,၀၉၁.၅၁၁,၀၉၀.၄၀၁,၀၉၀.၄၀၁,၀၇၃.၆၉——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၅၅%
၆၀၆.၇၄
-၃.၃၇
-၀.၅၅%
—၆၁၀.၁၁၆၁၀.၁၁၆၁၀.၂၉၆၀၆.၁၇——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၈၈%
၁,၂၄၈.၈၂
+၁၀.၈၄
+၀.၈၈%
—၁,၂၃၇.၉၈၁,၂၃၇.၈၃၁,၂၅၂.၄၁၁,၂၂၅.၀၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၁၇%
၁,၇၂၄.၃၆
-၂၀.၃၅
-၁.၁၇%
—၁,၇၄၄.၇၁၁,၇၄၀.၉၅၁,၇၄၇.၂၉၁,၇၂၁.၅၇——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၇၂%
၆၃၅.၅၉
-၄.၅၉
-၀.၇၂%
—၆၄၀.၁၈၆၃၉.၉၂၆၄၃.၁၉၆၃၄.၇၃——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၇၆%
၈၄၃.၁၅
-၆.၄၃
-၀.၇၆%
—၈၄၉.၅၈၈၄၅.၂၇၈၅၁.၆၈၈၃၉.၄၇——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၅၅%
၂၁၆.၂၉
-၁.၁၉
-၀.၅၅%
—၂၁၇.၄၈၂၁၇.၄၈၂၁၈.၁၆၂၁၅.၅၁——
SIXT
Technology
SIXT
Technology
SIXT
+၀.၀၈%
၃,၂၆၃.၄၁
+၂.၇၂
+၀.၀၈%
—၃,၂၆၀.၆၉၃,၂၇၃.၃၆၃,၂၈၇.၈၁၃,၂၄၀.၇၈——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၃၄%
၉၃၉.၂၄
-၃.၂၁
-၀.၃၄%
—၉၄၂.၄၅၉၃၉.၃၉၉၄၈.၈၀၉၃၃.၉၈——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၂၉%
၁,၄၆၂.၅၆
-၄.၂၄
-၀.၂၉%
—၁,၄၆၆.၈၀၁,၄၆၄.၇၀၁,၄၆၇.၁၉၁,၄၅၈.၃၆——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၀.၇၁%
၂,၃၈၀.၄၀
-၁၇.၁၀
-၀.၇၁%
—၂,၃၉၇.၅၀၂,၃၉၅.၀၃၂,၄၁၂.၀၁၂,၃၇၀.၆၄——
EYPT:NASDAQ
EyePoint Inc
၁၃.၈၅ US$
+၃.၈၂%
(+၀.၅၁) 1D
၁၃.၈၅ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: မေ ၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EYPT...
Open
၁၃.၂၄ US$
High
၁၃.၈၈ US$
Low
၁၃.၁၀ US$
Mkt. cap
၁၁၆.၀၆ ဋေ
Avg. vol.
၈.၉၄ သိန်း
Volume
၁.၀၆ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၅.၃၀ US$
EPS
-၃.၁၇ US$
Beta
၁.၇၆
Shares outstanding
၈.၃၈ ကုဋေ
No. of employees
၂၁၄
News stories
From sources across the web
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees၂၁၄
Founded၂၀၀၀
HeadquartersWatertown, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteeyepoint.bio
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၂.၄၅ ကုဋေ
၅.၃၃ သန်း
၉.၆၆ သိန်း
၆.၂၀ သိန်း
Cost of goods sold
၅.၈၄ ကုဋေ
၅.၄၇ ကုဋေ
၄.၇၅ ကုဋေ
၅.၈၆ ကုဋေ
Cost of revenue
၅.၈၄ ကုဋေ
၅.၄၇ ကုဋေ
၄.၇၅ ကုဋေ
၅.၈၆ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၄၉ ကုဋေ
၁.၂၉ ကုဋေ
၁.၅၅ ကုဋေ
၁.၂၄ ကုဋေ
Operating expense
၁.၄၉ ကုဋေ
၁.၂၉ ကုဋေ
၁.၅၅ ကုဋေ
၁.၂၄ ကုဋေ
Total operating expenses
၇.၃၃ ကုဋေ
၆.၇၆ ကုဋေ
၆.၃၀ ကုဋေ
၇.၁၀ ကုဋေ
Operating income
-၄.၈၈ ကုဋေ
-၆.၂၂ ကုဋေ
-၆.၂၀ ကုဋေ
-၇.၀၃ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၄.၅၂ ကုဋေ
-၅.၉၃ ကုဋေ
-၅.၉၇ ကုဋေ
-၆.၇၄ ကုဋေ
EBT excluding unusual items
-၄.၅၂ ကုဋေ
-၅.၉၃ ကုဋေ
-၅.၉၇ ကုဋေ
-၆.၇၄ ကုဋေ
Income tax expense
-
၉.၃၀ သောင်း
-
၁.၈၆ သိန်း
Effective tax rate
-
-၀.၁၆%
-
-၀.၂၈%
Other operating expenses
-
-
-
-
Net income
-၄.၅၂ ကုဋေ
-၅.၉၄ ကုဋေ
-၅.၉၇ ကုဋေ
-၆.၇၆ ကုဋေ
Net profit margin
-၁၈၄.၈၂%
-၁,၁၁၄.၃၁%
-၆,၁၈၃.၄၄%
-၁၀,၉၀၄.၆၈%
Earnings per share
-၀.၆၅
-၀.၈၅
-၀.၈၅
-၀.၈၁
Interest and investment income
၃.၆၄ သန်း
၂.၈၉ သန်း
၂.၂၉ သန်း
၂.၉၆ သန်း
Interest expense
-
-
-
-၃.၃၀ သောင်း
Net interest expenses
၃.၆၄ သန်း
၂.၈၉ သန်း
၂.၂၉ သန်း
၂.၉၂ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၈၃ ကုဋေ
-၆.၁၇ ကုဋေ
-၆.၁၄ ကုဋေ
-၆.၉၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer